Back to Search
Start Over
Clinical evidences of urea at medium concentration
- Publication Year :
- 2020
-
Abstract
- Urea-based topical compounds at medium concentrations (15%-30%) represent useful dermatological agents for their humectant and keratolytic effects by enhancing stratum corneum hydration and by loosening epidermal keratin, respectively. The aim of this paper is to review the clinical evidences of the use of 15%-30% urea as single topical agent. Although limited evidence supports the use of these concentrations of urea in skin disorders characterised by xerosis and hyperkeratosis, in clinical practice they are largely used especially in xerosis of limited skin areas, in which the side effects are tolerable, or hyperkeratosis involving large or more sensitive (eg, face, genital region, etc) areas, in which higher concentration may be irritant. In addition, urea at medium concentrations is used in combination with other substances including topical antifungals as penetration enhancer.
- Subjects :
- integumentary system
business.industry
Penetration enhancer
Hyperkeratosis
Keratolytic
General Medicine
030204 cardiovascular system & hematology
Pharmacology
medicine.disease
Humectant
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
medicine.anatomical_structure
chemistry
Stratum corneum
Genital region
Urea
Medicine
Humans
030212 general & internal medicine
Limited evidence
business
Skin
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....c5035df24b788a00d9233f2510f32acb